1Zmuda JM, Cauley JA, Ferrell Re. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev, 2000,22(2): 203 - 217
2Bortman P, Folgueira MAAK, Katayama MLH. Antiproliferative effects of 1,25- Dihydroxyvitamin D3 on breast cells - A mini review .Braz J Med Biol Res ,2002, 35(1):1-9
3Penna G, Adorini L. 1,25 - Dihydroxyvitamin D3 inhibits differentiation,maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol ,2000, 164:4443-4451
4Ambrosio DD, Cippitelli M, Cocciolo MG et al . Inhibition of IL - 12production by 1,25 - Dihydroxyvitamin D3. Involvement of NF - κBdownregulation in transcriptional repression of the P40 gene. J Clin Invest , 1998,101:252 - 262
5Takeuchi A, Reddy G, Kobayashi T et al . Nuclear factor of activated T cells(NFAT) as a molecular target for 1α,25 - Dihydroxyvitamin D3-mediated effects. J Immunol, 1998 ,160:209-218
6Gregori S, Casorati M, Amuchastegui S et al . Regulatory T cells induced by 1α, 25 - Dihydroxyvitamin D3 and mycophenolate mofeti treatment mediate transplantation tolerance. J Immunol, 2001,167:1945- 1 953
7Mathieu C, Laurey J, Sobis H et al . 1,25- Dihydroxyvitamin D3prevents insulitis in NOD mice. Diabetes , 1992, 41 ( 11 ): 1 491 - 1495
8Mathieu C, Waer M, Casteels K et al . Prevention of type Ⅰ Diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25 - Dihydroxyvitamin D3, KH1060. Endocrinology, 1995,136(3):866 - 872
9Zella JB, Deluc a HF. Vitamin D and Autoimmune Diabetes. J Cell Biochem, 2003,88(2) :216 - 222
10Riachy R, Vandewalle B, Belaich S et al . Beneficial effect of 1,25- Dihydroxyvitamin D3 on cytokine- treated human pancreatic islets.J Endocrinology,2001,169:161 - 168
4Ylikomi T, Laaksi I, Rulou Y, et al. Anti-poliferative action of vitamin D[J].Vitamins and Hormones, 2002,64:357-406.
5Lewis SJ ,Baker I,Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk[J]. Int J Tuberc Lung Dis. 2005,9 ( 10 ):1174-7.
6Zmuda JM,Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants[J]. Epiderniol Rev. 2000,22(2) : 203-17.
7Bellamy R,Ruwende C,Corrah T,et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene[J].Infect Dis. 1999,179(2) : 721-4.
8Lombard Z,Dalton DL, Venter PA, et al. Association of HLADR, -DQ, and vitamin D receptor alleles haplotypes with tuberculosis in the Venda of South Afriea[J]. Hum Immunol. 2006,67(8): 643-54.
9Olesen R,Wejse C,Velez DR ,et al. DC-SIGN(CD209) ,pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans[J].Genes Immun. 2007, 8(6):456-67.
10Babb C, vander ML, Beyers N, et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients[J].Tuberculosis(Edinb). 2007,87(4):295-302.
